The Fragmentome

  • Post author:
  • Reading time:24 mins read

(Analysis done by Adriano Rutz and Nicola Zamboni, updated on Nov. 3, 2026) We are used to perceiving any experimental MS/MS spectrum as a list of mass-to-charge ratios and intensities, not a list of molecules. We are confident about their elemental composition, but what do we actually know about their chemical structure? There is sporadic experimental information on specific compounds analyzed in depth by…

Continue ReadingThe Fragmentome

First-principles calculation of multimodal spectroscopy data in milliseconds

  • Post author:
  • Reading time:32 mins read

While developing QUACK (QUAntum Chemistry Kit) - a fast, first-principles quantum-chemical engine originally built to predict tandem mass spectra (MS2 and multi-stage MSn across CID, HCD, EID, UVPD, and IRMPD; see our earlier post on lipid conformations) - we realized that because the engine already computes a 3D wavefunction, charge distribution, and energy landscape in microseconds, we could plug standard textbook formulas for other…

Continue ReadingFirst-principles calculation of multimodal spectroscopy data in milliseconds

Quantum-chemistry-based elucidation of stereochemistry in polyunsaturated lipids by EID and UVPD.

  • Post author:
  • Reading time:41 mins read

In routine lipidomics, low-energy Collision-Induced Dissociation (CID) is the workhorse for MS2 fragmentation, but is not sufficient for full structural elucidation [1, 2]. The reason is inherent to the mechanism: CID heats ions slowly through multiple collisions with neutral gas atoms (N2 or Ar), and vibrational energy redistributes across the entire molecule before any bond breaks. Consequently, CID cleaves only the weakest linkages in…

Continue ReadingQuantum-chemistry-based elucidation of stereochemistry in polyunsaturated lipids by EID and UVPD.

Translating lipid shorthand notation into extended CXSMILES, and back.

  • Post author:
  • Reading time:11 mins read

The initial post on lipid annotation in CXSMILES was flawed but has since been revised. The new approach adheres to SMILES standards, with a distinction between chemically valid structures and unrepresented features stored after closing pipes. The revision efficiently communicates constraints and unlocalised positions using invented tokens, ensuring clarity in representation.

Continue ReadingTranslating lipid shorthand notation into extended CXSMILES, and back.

FaIr representation of ambiguous lipid annotation

  • Post author:
  • Reading time:27 mins read

One of the recurring themes of our work is how to make results clear to the rest of the world. This is the I in the FAIR principles: interoperable. Generally speaking, this challenge boils down to using a common language or an ontology to describe an object or a relation. In metabolomics, however, we regularly have to deal with another level of information: confidence,…

Continue ReadingFaIr representation of ambiguous lipid annotation

The fun part of analysing untargeted metabolomics data

  • Post author:
  • Reading time:27 mins read

This is the second part of our mini-series on how we analyse untargeted metabolomics data. After outlining the needs and the core processing logic in Part I, we now turn to how all the parts come together with orchestration, user experience, zero-knowledge processing, FAIR reporting, benchmarking, and automation. Spoiler: it's actually a lot of fun! 10. One architecture to serve them all? One of…

Continue ReadingThe fun part of analysing untargeted metabolomics data

How we analyse untargeted metabolomics data

  • Post author:
  • Reading time:28 mins read

As a lab primarily interested in metabolomics applications, our publications usually focus on the biological results and their relevance. Much more rarely do we describe the infrastructure that turns raw LC-MS/MS data into detected features, annotations, and ultimately the files that accompany a publication, whether tables, mzTab exports, or other deliverables. We sometimes allude to this infrastructure in talks, but there is rarely enough…

Continue ReadingHow we analyse untargeted metabolomics data

The perfect mass spectrometer for metabolomics

  • Post author:
  • Reading time:15 mins read

ASMS is just around the corner, and we are all eager to meet both old and new colleagues, network, and seek inspiration from thousands of posters. For the galaxy of companies that orbit mass spectrometers (MS), it’s the prime stage to launch new products and concepts. As a user and consumer, I am also curious. Some of these will be pleasantly surprising and inspiring,…

Continue ReadingThe perfect mass spectrometer for metabolomics

70% in-source fragments? The data tells a different story!

  • Post author:
  • Reading time:8 mins read

A recent commentary by Giera et al. (link) sparked a discussion about in-source fragmentation (ISF). The authors claimed that “ISF could account for over 70% of the peaks observed in typical LC–MS/MS metabolomic datasets”. This claim, echoed by other outlets, even went as far as suggesting that “over 70% of the dark metabolome could be an experimental artefact” (link). Many metabolomics practitioners reacted with…

Continue Reading70% in-source fragments? The data tells a different story!

On the benefits and role of electron-induced dissociation in lipidomics

  • Post author:
  • Reading time:32 mins read

NOTE: Results and software are available on ChemRxiv One of the grand challenges in metabolomics using mass spectrometry (MS) is the limited and somewhat redundant information provided by collision-induced dissociation (CID). CID is incredibly versatile and quick but tends to fragment weaker bonds, such as C-O bonds. This bias allows us to easily observe fragments indicative of specific functional groups—such as ethanolamine, phosphatidic groups,…

Continue ReadingOn the benefits and role of electron-induced dissociation in lipidomics